Regulus Therapeutics | RGLS - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Regulus Therapeutics

Regulus Therapeutics reported $3.72M in Debt for its fiscal quarter ending in March of 2023.


Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
AstraZeneca AZN:LN USD 31.5B 2.27B
Biogen BIIB:US USD 6.28B 1.7M
GlaxoSmithKline GSK:LN GBP 20.9B 82M
Incyte Corp INCY:US USD 32.85M 414K
Intercept Pharmaceuticals ICPT:US USD 333.04M 367K
Intrexon XON:US USD 13.82M 29.4M
Ionis Pharmaceuticals IONS:US USD 1.19B 2.36M
Lexicon Pharmaceuticals LXRX:US USD 48.84M 266K
Ligand Pharmaceuticals LGND:US USD 76.83M 93K
Regulus Therapeutics RGLS:US USD 3.72M 795K
Spectrum Pharmaceuticals SPPI:US USD 28.84M 174K
Takeda 4502:JP JPY 4.38T 95.44B